The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Search

      
      View

Article / Jun 30, 2023
Excellence in pharmaceuticalsUSA Today, 30 June 2023

      View

Press Clipping / Mar 19, 2020
Stepping up to the hand sanitizer shortageChemical companies, breweries, and perfumeries take to making and donating a vital commodity in short supply

    Hovione Capacity ExpansionHovione is Growing

      View

Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy SolutionsCommitment to partnership and joint innovation for cell and gene therapies

      View

News / Mar 10, 2021
It's B Corp MonthWe are proud to be a B Corporation.

      View

Press Release / Aug 23, 2022
Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticalsHovione today announced an extension of collaboration on Zerion’s Dispersome® technology into the nutraceutical/dietary supplements field.

      View

Press Clipping / Oct 27, 2025
Hovione Completes Initial $100M Investment Cycle to Expand U.S. Operations at New Jersey Manufacturing SiteInnovations in Pharmaceutical Technology, IPT Online, 27 October 2025

      View

News / Apr 28, 2021
World Day for Safety and Health at WorkSafety First, Quality Always

      View

Press Clipping / Apr 06, 2023
Hovione 2023 CDMO Leadership Awards Winner InterviewOutsourced Pharma, April 2023

      View

Press Clipping / Nov 12, 2018
How Hovione grew from a basement lab to a global pharmaceutical services companyC&EN, November 12, 2018

Browser not supported

Search

Types

Press Room

Categories

Excellence in pharmaceuticals

Stepping up to the hand sanitizer shortage

Hovione Capacity Expansion

Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions

It's B Corp Month

Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals

Hovione Completes Initial $100M Investment Cycle to Expand U.S. Operations at New Jersey Manufacturing Site

World Day for Safety and Health at Work

Hovione 2023 CDMO Leadership Awards Winner Interview

How Hovione grew from a basement lab to a global pharmaceutical services company